Submitted:
04 July 2024
Posted:
05 July 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
1.1. Definition
1.2. Epidemiology
1.3. Methods of treatment
2. Material and method
2.1. Selection of patients
2.2. Stages of implementation
2.3. Studied factors
- Demographic parameters (age, sex, average);
- Paraclinical balance at admission: CBC: (Hemoglobin, hematocrit, leucocytes, polymorphonuclear, lymphocytes, monocytes, eosinophils, thrombocytes), erythrocyte sedimentation speed, time of partially activated thromboplastin, prothrombin Quick time, prothrombin index, international normalized ratio, fibrinogen, natrium, potassium, blood glucose, urea, creatinine, bilirubin, aspartate aminotransferase, alanine aminotransferase, triglyceride, cholesterol, blood type, antigen on the surface of red blood cells;
- Electrocardiogram: RS segment, PR segment, QRS complex, QT segment, TS segment, atrial fibrillation, QRS axis, T wave;
- Radiological examination-cardio-thoracic index;
- Preoperative echocardiography: end-diastolic diameter of the left ventricle(mm), end-systolic diameter of the left ventricle (mm), fractional shortening(%), ejection fraction (%), volumetric ejection fraction(%), right atrium(mm), end-diastolic diameter of right ventricle(mm), surface of the mitral orifice(cm2), maximum gradient of the tricuspid valve, movement of the tricuspid ring during systole, mitral valve insufficiency, aortic valve insufficiency, pulmonary valve insufficiency, tricuspid valve insufficiency;
- Paraclinical balance at discharge: CBC: (Hemoglobin, hematocrit, leucocytes, polymorphonuclear leukocytes , lymphocytes, monocytes, eosinophils, thrombocytes), erythrocyte sedimentation speed, time of partially activated thromboplastin, prothrombin Quick time, prothrombin index, international normalized ratio, fibrinogen, natrium, potassium, blood glucose, urea, creatinine, bilirubin, aspartate aminotransferase, alanine aminotransferase, triglyceride, cholesterol, blood type, antigen on the surface of red blood cells;
- Postoperative echocardiography: end-diastolic diameter of the left ventricle(mm), end-systolic diameter of the left ventricle (mm), fractional shortening(%), ejection fraction (%), volumetric ejection fraction(%), right atrium(mm), end-diastolic diameter of right ventricle(mm), surface of the mitral orifice(cm2), maximum gradient of the tricuspid valve, movement of the tricuspid ring during systole, mitral valve insufficiency, aortic valve insufficiency, pulmonary valve insufficiency, tricuspid valve insufficiency;
- Data from the intraoperative protocol: aorta clamping time (min), total extracorporeal circulation time (min), height (cm), weight (kg), extracorporeal circulation temperature (degrees Celsius), blood/cardioplegia, extracorporeal circulation balance sheet (ml);
- Total days in the intensive care unit (ICU) were divided into 4 periods to see the evolution of patients during the stationing there, ICU’s balance sheet 1( INITIAL), 2, 3 and 4 (FINAL), containing: urea, creatinine, creatine kinase-MB, hemoglobin, hematocrit, leucocytes, thrombocytes, red blood cells, prothrombin Quick time, total bilirubin, aspartate aminotransferase, alanine aminotransferase, prothrombin activity(sec), the activity of the international normalized ratio (%) prothrombin activity (%), fibrinogen, time of partially activated thromboplastin.
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Data Availability Statement
Conflicts of Interest
References
- N. Hirata, Y. Sawa, H. Matsuda, Predictive value of preoperative serum cholinesterase concentration in patients with liver dysfunction undergoing cardiac surgery, J. Card. Surg. 14 (1999) 172–177.
- J.D. Klemperer, W. Ko, K.H. Krieger, et al., Cardiac operations in patients with cirrhosis, Ann. Thorac. Surg. 65 (1998) 85–87.
- C.C. Giallourakis, P.M. Rosenberg, L.S. Friedman, The liver in heart failure, Clin. Liver Dis. 6 (Nov 2002) 947–967 viii–ix.
- A.M. Alvarez, D. Mukherjee, Liver abnormalities in cardiac diseases and heart failure, Int. J. Angiol. 20 (Sep 2011) 135–142.
- L.S. Friedman, The risk of surgery in patients with liver disease, Hepatology 29 (Jun 1999) 1617–1623.
- J.G. O'Leary, P.S. Yachimski, L.S. Friedman, Surgery in the patient with liver disease, Clin. Liver Dis. 13 (09) 211–231. 20 May.
- Y. Sugimura, M. Toyama, M. Katoh, Y. Kato, K. Hisamoto, Analysis of open heart surgery in patients with liver cirrhosis, Asian Cardiovasc. Thorac. Ann. 20 (Jun 2012) 263–268.
- Y. An, Y.B. Xiao, Q.J. Zhong, Open-heart surgery in patients with liver cirrhosis: indications, risk factors, and clinical outcomes, Eur. Surg. Res. 39 (2007) 67–74.
- A1. Ziser, D.J. Plevak, R.H. Wiesner, J. Rakela, K.P. Offord, D.L. Brown, Morbidity and mortality in cirrhotic patients undergoing, Anesthesiology 90 (Jan 1999) 42–53.
- J.G. O'Leary, L.S. Friedman, Predicting surgical risk in patients with cirrhosis: from art to science, Gastroenterology 132 (Apr 2007) 1609–1611.
- P.S. Kamath, R.H. Wiesner, M. Malinchoc, et al., A model to predict survival in patients with end-stage liver disease, Hepatology 33 (Feb 2001) 464–470.
- R.B. Freeman, R.H. Wiesner, E. Edwards, et al., Results of the first year of the new liver allocation plan, Liver Transpl. 10 (Jan 2004) 7–15.
- E.L. Godfrey, M.L. Kueht, A. Rana, S. Awad, MELD-Na (the new MELD) and peri-operative outcomes in emergency surgery. Am J Surg. 2018 Sep;216(3):407-413. [CrossRef] [PubMed]
- U. Kartoun, K.E. Corey, T.G. Simon, H. Zheng, R. Aggarwal, K. Ng, S.Y. Shaw, The MELD-Plus: A generalizable prediction risk score in cirrhosis, PLOS ONE. [CrossRef]
- S. Liao, X. Lu, I. Cheang, X. Zhu, T. Yin, W. Yao, et al., Prognostic value of the modified model for end-stage liver disease (MELD) score including albumin in acute heart failure. BMC Cardiovasc Disord 2021;21(1):128. [CrossRef]
- F. Filsoufi, S.P. Salzberg, P.B. Rahmanian, et al., Early and late outcome of cardiac surgery in patients with liver cirrhosis, Liver Transpl. 13 (Jul 2007) 990–995.
- R. Cooper, J. Cutler, P. Desvigne-Nickens, et al., Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation 2000;102:3137-47.
- P. Greenland, J.S. Alpert, G.A. Beller, et al., 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Asociation Task Force on Practice Guidelines. J Am Coll Cardiol 2010;56:e50-103.
- S.M. Grundy, N.J. Stone, A.L. Bailey, et al., 2018 AHA/ACC/ AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2019;73:e285-350.
- H. Gerard, M.D. Daly, MSc, Coronary Artery Disease, Ferri's Clinical Advisor 2023, 438-447.e1.
- T. Doenst, H. Thiele, J. Haasenritter, T. Wahlers, S. Massberg, A. Haverich, The Treatment of Coronary Artery Disease, Dtsch Arztebl Int. 2022 Oct 21;119(42):716-723. [CrossRef]
- J. Knuuti, W. Wijns, A. Saraste, et al., 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020; 41: 407–77.
- F.J. Neumann, M. Sousa-Uva, A. Ahlsson, et al., 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019; 40: 87–165.
- J.P. Collet, H. Thiele, E. Barbato, et al., 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2021; 42: 1289–367.
- N. Farnsworth, S.P. Fagan, D.H. Berger, S.S. Awad, Child–Turcotte–Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients, Am. J. Surg. 188 (Nov 2004) 580–583.
- F. Durand, D. Valla, Assessment of the prognosis of cirrhosis: Child–Pugh versus MELD, J. Hepatol. 42 (Suppl) (2005) S100–S107.
- L.M. Forman, M.R. Lucey, Predicting the prognosis of chronic liver disease: an evolution from child to MELD, Mayo End-Stage Liver Dis. Hepatol. 33 (Feb 2001) 473–475.
- L. Araujo, V. Dombrovskiy, W. Kamran, A. Lemaire, A. Chiricolo, Y.L. Lee, et al., The effect of preoperative liver dysfunction on cardiac surgery outcomes. J Cardiothorac Surg 2017;12:73.
- A.H. Chou, T.H. Chen, C.Y. Chen, S.W. Chen, C.W. Lee, C.H. Liao, et al., Longterm outcome of cardiac surgery in 1,040 liver cirrhosis patient- nationwide population-based cohort study. Circ J 2017;81:476–84.
- M.R. Movahed, R. Ramaraj, A. Khoynezhad, M. Hashemzadeh, M. Hashemzadeh, Declining In-Hospital Mortality in Patients Undergoing Coronary Bypass Surgery in the United States Irrespective of Presence of Type 2 Diabetes or Congestive Heart Failure, Clin. Cardiol. 35, 5, 297–300 (2012) Published online in Wiley Online Library (wileyonlinelibrary.com). [CrossRef]
| MELD Score | 3-Month Mortality (%) | Meld Class |
| < 9 | 1.9%- 3.7% | 1 |
| 10 to 19 | 6%- 20% | 2 |
| 20 to 29 | 19.6%- 45.5% | 3 |
| 30 to 39 | 52.6%- 74.5% | 4 |
| >40 | 71%- 100% | 5 |
| Descriptive statistics | N | Min | Max | Mean | Std. Error | Std. Dev. | Variance | Skewness | Std. Error |
|---|---|---|---|---|---|---|---|---|---|
| MELD score | 589 | 0.08 | 30.78 | 6.25 | 1.63 | 3.96 | 15.75 | 1.97 | 0.101 |
| Hopitalization days | 589 | 1 | 137 | 19.35 | 3.69 | 8.96 | 80.39 | 5.15 | 0.101 |
| Clamping time of the aorta | 589 | 15 | 653 | 86.92 | 1.52 | 37.11 | 1377.51 | 6.51 | 0.101 |
| Extracorporeal circulation time | 589 | 22 | 582 | 118.28 | 1.70 | 41.47 | 1720.10 | 3.36 | 0.101 |
| Days in ICU’s | 588 | 3 | 57 | 7.25 | 1.73 | 4.21 | 17.72 | 5.12 | 0.101 |
| Age | 589 | 31 | 83 | 63.11 | 3.69 | 8.96 | 80.33 | -0.51 | 0.101 |
| Valid N (listwise) | 588 |
| Model | R | R Square | Adjusted R Square | Std. Error of the Estimate | Change Statistics | Durbin-Watson | ||||
| R Square Change | F Change | df1 | df2 | Sig. F Change | ||||||
| 1 | 0.223a | 0.115 | 0.113 | 3.94158 | 0.015 | 8.908 | 1 | 584 | 0.003 | |
| 2 | 0.226b | 0.116 | 0.113 | 3.94310 | 0.001 | 0.549 | 1 | 583 | 0.049 | |
| 3 | 0.227c | 0.116 | 0.111 | 3.94601 | 0.000 | 0.142 | 1 | 582 | 0.046 | |
| 4 | 0.272d | 0.168 | 0.162 | 3.84303 | 0.052 | 32.608 | 1 | 581 | 0.000 | |
| 5 | 0.283e | 0.169 | 0.161 | 3.84457 | 0.001 | 0.534 | 1 | 580 | 0.045 | |
| 6 | 0.342f | 0.217 | 0.207 | 3.74882 | 0.047 | 31.008 | 1 | 579 | 0.000 | 1.896 |
| Model | Sum of Squares | df | Mean Square | F | Sig. | |
|---|---|---|---|---|---|---|
| 1 | Regression | 138.40 | 1 | 138.40 | 8.90 | 0.003a |
| Residual | 9073.04 | 584 | 15.53 | |||
| Total | 9211.44 | 585 | ||||
| 2 | Regression | 146.93 | 2 | 73.46 | 4.72 | 0.009b |
| Residual | 9064.51 | 583 | 15.54 | |||
| Total | 9211.44 | 585 | ||||
| 3 | Regression | 149.14 | 3 | 49.71 | 3.19 | 0.023c |
| Residual | 9062.30 | 582 | 15.57 | |||
| Total | 9211.44 | 585 | ||||
| 4 | Regression | 630.72 | 4 | 157.68 | 10.67 | 0.000d |
| Residual | 8580.71 | 581 | 14.76 | |||
| Total | 9211.44 | 585 | ||||
| 5 | Regression | 638.62 | 5 | 127.72 | 8.64 | 0.000e |
| Residual | 8572.82 | 580 | 14.78 | |||
| Total | 9211.44 | 585 | ||||
| 6 | Regression | 1074.39 | 6 | 179.06 | 12.74 | 0.000f |
| Residual | 8137.05 | 579 | 14.05 | |||
| Total | 9211.44 | 585 | ||||
| Model | Unstandardized Coefficients | Std. Coefficients | t | Sig. | 95% Confidence Interval for B | Collinearity Statistics | ||||
| B | Std. Error | Beta | Lower Bound | Upper Bound | Tolerance | VIF | ||||
| 1 | (Constant) | 5.213 | 0.387 | 13.45 | 0 | 4.45 | 5.97 | |||
| Hospitalization days | 0.054 | 0.018 | 0.22 | 2.98 | 0.003 | 0.01 | 0,09 | 1.000 | 1.00 | |
| 2 | (Constant) | 4.967 | 0.510 | 9.73 | 0.000 | 3.96 | 5.96 | |||
| Hospitalization days | 0.052 | 0.018 | 0.021 | 2.83 | 0.005 | 0.016 | 0.08 | 0.977 | 1.02 | |
| Clamping time of the aorta | 0.003 | 0.004 | 0.23 | 0.74 | 0.049 | -0.005 | 0.01 | 0.977 | 1.02 | |
| 3 | (Constant) | 5.058 | 0.564 | 8.96 | 0 | 3.94 | 6.16 | |||
| Hospitalization days | 0.053 | 0.019 | 0.22 | 2.85 | 0.004 | 0.017 | 0.09 | 0.944 | 1.06 | |
| Clamping time of the aorta | 0.007 | 0.011 | 0.267 | 0.63 | 0.024 | -0.015 | 0.02 | 0.152 | 6.59 | |
| Extracorporeal circulation time | -0.004 | 0.010 | -0.140 | -0.37 | 0.046 | -0.024 | 0.01 | 0.148 | 6.74 | |
| 4 | (Constant) | 4.394 | 0.562 | 7.82 | 0 | 3.29 | 5.49 | |||
| Hospitalization days | 0.017 | 0.019 | 0.238 | 0.859 | 0.039 | -0.021 | 0.055 | 0.839 | 1.192 | |
| Clamping time of the aorta | 0.008 | 0.011 | 0.272 | 0.700 | 0.044 | -0.014 | 0.029 | 0.152 | 6.598 | |
| Extracorporeal circulation time | -0.007 | 0.010 | -0.171 | -0.686 | 0.049 | -0.026 | 0.013 | 0.148 | 6.765 | |
| ICU’s days | 0.232 | 0.041 | 0.247 | 5.710 | 0.000 | 0.152 | 0.312 | 0.858 | 1.165 | |
| 5 | (Constant) | 3.604 | 1.219 | 2.955 | 0.003 | 1.209 | 5.998 | |||
| Hospitalization days | 0.016 | 0.019 | 0.236 | 0.825 | 0.041 | -0.022 | 0.054 | 0.837 | 1.195 | |
| Clamping time of the aorta | 0.007 | 0.011 | 0.263 | 0.610 | 0.042 | -0.015 | 0.028 | 0.150 | 6.688 | |
| Extracorporeal circulation time | -0.006 | 0.010 | -0.165 | -0.619 | 0.036 | -0.026 | 0.013 | 0.147 | 6.817 | |
| ICU’s days | 0.229 | 0.041 | 0.243 | 5.573 | 0.000 | 0.148 | 0.309 | 0.845 | 1.183 | |
| Age | 0.013 | 0.018 | 0.230 | 0.731 | 0.046 | -0.022 | 0.049 | 0.959 | 1.042 | |
| 6 | (Constant) | 5.360 | 1.230 | 4.357 | 0.000 | 2.944 | 7.776 | |||
| Hospitalization days | 0.027 | 0.019 | 0.260 | 1.403 | 0.041 | -0.011 | 0.064 | 0.828 | 1.207 | |
| Clamping time of the aorta | 0.004 | 0.011 | 0.240 | 0.397 | 0.049 | -0.017 | 0.025 | 0.149 | 6.700 | |
| Extracorporeal circulation time | -0.005 | 0.010 | -0.048 | -0.471 | 0.038 | -0.024 | 0.015 | 0.147 | 6.823 | |
| ICU’s days | 0.221 | 0.040 | 0.235 | 5.518 | 0.000 | 0.142 | 0.299 | 0.844 | 1.185 | |
| Age | 0.024 | 0.018 | 0.055 | 1.368 | 0.012 | -0.011 | 0.059 | 0.947 | 1.056 | |
| Gender | -2.120 | 0.381 | -0.220 | -5.568 | 0.000 | -2.868 | -1.372 | 0.975 | 1.026 | |
| Correlations | Meld score | Hospitalisation days | Clamping time of the aorta | Extracorporeal circulation time | ICU days | age | Gender | |
| Meld score | Pearson Correlation | 1 | 0.226** | 0.151 | 0.150 | 0.259** | 0.177* | -0.208** |
| Sig. (2-tailed) | 0.002 | 0.220 | 0.227 | 0.000 | 0.042 | 0.000 | ||
| N | 589 | 589 | 589 | 589 | 588 | 589 | 587 | |
| Hospitalization days | Pearson Correlation | 0.226** | 1 | 0.152** | 0.212** | 0.362** | 0.196* | 0.103* |
| Sig. (2-tailed) | 0.002 | 0.000 | 0.000 | 0.000 | 0.020 | 0.013 | ||
| N | 589 | 589 | 589 | 589 | 588 | 589 | 587 | |
| Clamping time of the aorta | Pearson Correlation | 0.151 | 0.152** | 1 | 0.920** | 0.148** | 0.118** | -0.014 |
| Sig. (2-tailed) | 0.220 | 0.000 | 0.000 | 0.000 | 0.004 | 0.728 | ||
| N | 589 | 589 | 589 | 589 | 588 | 589 | 587 | |
| Extracorporeal circulation time | Pearson Correlation | 0.150 | 0.212** | 0.920** | 1 | 0.180** | 0.185* | 0.000 |
| Sig. (2-tailed) | 0.227 | 0.000 | 0.000 | 0.000 | 0.040 | 0.993 | ||
| N | 589 | 589 | 589 | 589 | 588 | 589 | 587 | |
| ICU’s days | Pearson Correlation | 0.259** | 0.362** | 0.148** | 0.180** | 1 | 0.154** | 0.017 |
| Sig. (2-tailed) | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.674 | ||
| N | 588 | 588 | 588 | 588 | 588 | 588 | 586 | |
| Age | Pearson Correlation | 0.177* | 0.196* | 0.118** | 0.185* | 0.154** | 1 | 0.106** |
| Sig. (2-tailed) | 0.042 | 0.020 | 0.004 | 0.040 | 0.000 | 0.010 | ||
| N | 589 | 589 | 589 | 589 | 588 | 589 | 587 | |
| Gender | Pearson Correlation | -0.208** | 0.103* | -0.014 | 0.000 | 0.017 | 0.106** | 1 |
| Sig. (2-tailed) | 0.000 | 0.013 | 0.728 | 0.993 | 0.674 | 0.010 | ||
| N | 587 | 587 | 587 | 587 | 586 | 587 | 587 | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).